Snapshots Argentina Pharmaceuticals 2009Mintel - SnapshotsApril 29, 2009 17 Pages - SKU: SNAP2266234 |
|
Central America Pharmaceuticals and Healthcare Report Q3 2013
5/1/2013 | published by: Business Monitor International
BMI View: Commercial incentives for foreign drugmakers to expand in the Central Americanpharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending andmarket growth. However, the heavy reliance on imported medicine in
|
read more...
|
$1,175.00
|
|
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI
|
read more...
|
$1,175.00
|
|
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers
|
read more...
|
$1,175.00
|
|
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country's shortcomingsinclude poor public health provision and rampant corruption. Consequently
|
read more...
|
$1,175.00
|
|
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn
|
read more...
|
$1,175.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
Executive Summary BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We do notbelieve implementing a selected import ban on pharmaceuticals should
|
read more...
|
$1,175.00
|
|
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
4/30/2013 | published by: GlobalData
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry Summary PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
|
read more...
|
$2,995.00
|
|
Pneumonia Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for pneumonia treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
read more...
|
$2,000.00
|
|
Chemical & Pharmaceutical Plant Construction in Belgium to 2017: Market Databook
5/13/2013 | published by: Timetric
Chemical & Pharmaceutical Plant Construction in Belgium to 2017: Market Databook Synopsis Timetric’s 'Chemical & Pharmaceutical Plant Construction in Belgium to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical
|
read more...
|
$500.00
|
|
Chemical & Pharmaceutical Plant Construction in Chile to 2017: Market Databook
5/13/2013 | published by: Timetric
Chemical & Pharmaceutical Plant Construction in Chile to 2017: Market Databook Synopsis Timetric’s 'Chemical & Pharmaceutical Plant Construction in Chile to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical
|
read more...
|
$500.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Manufacturing, Packaging & Detailing Reports